ImmuneWatch
QIAGEN
TCR Sequencing Grant Program
Now Open for Applications

Free TCR Sequencing & Analysis for Your Research

ImmuneWatch and QIAGEN are funding up to 4 research projects - 2 from academia, 2 from for-profit - at no cost to you.

Application deadline: October 30, 2026

What Selected Projects Receive

🧪

RNA Extraction Kit

QIAGEN RNA extraction kit shipped directly to your lab, ready to process your samples.

Free
🔬

TCR-seq Library Construction

Bulk-TCR-seq library preparation using the QIAseq Targeted RNA TCR Panel.

Free
💻

NGS Sequencing & Processing

Full next-generation sequencing and clonotype data processing, delivered by QIAGEN.

Free
🧠

TCR Intelligence Services

Expert TCR clustering and antigen–TCR annotations with ImmuneWatch DETECT by the ImmuneWatch analyst team.

Free

IDEAL PROJECTS

Project Focus

  • Longitudinal bulk TCR sequencing
  • TCR clone expansion or contraction
  • Antigen-specificity linked to disease or treatment response

Priority Research Areas

  • Cancer
  • Autoimmunity

Priority Applications

  • Patient stratification
  • Immune monitoring of immunotherapy, cell therapy, or vaccines

Eligibility Requirements

Institution
Academic, non-profit, or biopharma — non-profit and for-profit applicants evaluated separately.
Location
USA, Canada, UK, Ireland, Germany, France, Italy, Austria, Switzerland, Netherlands, Belgium, Poland, Finland, Sweden, Denmark, Norway
Samples
Human RNA (RIN > 5, ≥ 0.1 ng/µL) from solid tumor, enriched TILs, peripheral blood, or buffy coat. Samples must already be collected.
Scale
Up to 24 samples per grant award
Shipping
Must be able to extract and ship RNA on dry ice to Germany or USA
Timeline
Project completed within 6 months of selection
Commitment
Willingness to share applicant details and results for winner announcements and other communications related to the grant program
Review Criteria
Scientific merit, clinical relevance, and project feasibility

How to Apply

1

Submit Application

One-page form covering study title, abstract, methods, and expected outcomes. Deadline October 30, 2026.

2

Scientific Review

Assessed on scientific quality, innovation, and speed of execution.

3

Winners Notified

November 15, 2026 — up to 4 projects selected, followed by a public announcement.

4

Project Starts

Kits shipped, sequencing begins, results delivered within 6 months of selection.

Ready to Apply?

Up to 4 projects funded. Deadline October 30, 2026. Non-profit and for-profit applicants evaluated separately.

Apply Now

Questions? grant@immunewatch.com

In partnership with